Investigational Site Number :3800001
Torino 10126
0 studies enrolling now ยท 1 studies all time
What they study most
Plasma Cell Myeloma
Studies at this site
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
โ Completed